Your browser doesn't support javascript.
loading
FTLD targets brain regions expressing recently evolved genes.
Pasquini, Lorenzo; Pereira, Felipe L; Seddighi, Sahba; Zeng, Yi; Wei, Yongbin; Illán-Gala, Ignacio; Vatsavayai, Sarat C; Friedberg, Adit; Lee, Alex J; Brown, Jesse A; Spina, Salvatore; Grinberg, Lea T; Sirkis, Daniel W; Bonham, Luke W; Yokoyama, Jennifer S; Boxer, Adam L; Kramer, Joel H; Rosen, Howard J; Humphrey, Jack; Gitler, Aaron D; Miller, Bruce L; Pollard, Katherine S; Ward, Michael E; Seeley, William W.
Afiliação
  • Pasquini L; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
  • Pereira FL; Department of Neurology, Neuroscape, University of California, San Francisco, CA, USA.
  • Seddighi S; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
  • Zeng Y; National Institute of Neurological Disorders and Stroke, Bethesda, MD, USA.
  • Wei Y; Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA.
  • Illán-Gala I; School of Artificial Intelligence, Beijing University of Posts and Telecommunications, Beijing, China.
  • Vatsavayai SC; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
  • Friedberg A; Global Brain Health Institute, University of California, San Francisco, San Francisco, CA, USA and Trinity College Dublin, Dublin, Ireland.
  • Lee AJ; Department of Neurology, Hospital de la Santa Creu i Sant Pau, Biomedical Research Institute, Universitat Autònoma de Barcelona, Barcelona, Catalunya, Spain.
  • Brown JA; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
  • Spina S; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
  • Grinberg LT; Global Brain Health Institute, University of California, San Francisco, San Francisco, CA, USA and Trinity College Dublin, Dublin, Ireland.
  • Sirkis DW; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
  • Bonham LW; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
  • Yokoyama JS; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
  • Boxer AL; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
  • Kramer JH; Department of Pathology, University of California, San Francisco, CA, USA.
  • Rosen HJ; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
  • Humphrey J; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
  • Gitler AD; Department of Radiology, University of California, San Francisco, CA, USA.
  • Miller BL; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
  • Pollard KS; Department of Radiology, University of California, San Francisco, CA, USA.
  • Ward ME; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
  • Seeley WW; Department of Neurology, Memory and Aging Center, University of California, San Francisco, CA, USA.
medRxiv ; 2023 Oct 28.
Article em En | MEDLINE | ID: mdl-37961381
In frontotemporal lobar degeneration (FTLD), pathological protein aggregation is associated with a decline in human-specialized social-emotional and language functions. Most disease protein aggregates contain either TDP-43 (FTLD-TDP) or tau (FTLD-tau). Here, we explored whether FTLD targets brain regions that express genes containing human accelerated regions (HARs), conserved sequences that have undergone positive selection during recent human evolution. To this end, we used structural neuroimaging from patients with FTLD and normative human regional transcriptomic data to identify genes expressed in FTLD-targeted brain regions. We then integrated primate comparative genomic data to test our hypothesis that FTLD targets brain regions expressing recently evolved genes. In addition, we asked whether genes expressed in FTLD-targeted brain regions are enriched for genes that undergo cryptic splicing when TDP-43 function is impaired. We found that FTLD-TDP and FTLD-tau subtypes target brain regions that express overlapping and distinct genes, including many linked to neuromodulatory functions. Genes whose normative brain regional expression pattern correlated with FTLD cortical atrophy were strongly associated with HARs. Atrophy-correlated genes in FTLD-TDP showed greater overlap with TDP-43 cryptic splicing genes compared with atrophy-correlated genes in FTLD-tau. Cryptic splicing genes were enriched for HAR genes, and vice versa, but this effect was due to the confounding influence of gene length. Analyses performed at the individual-patient level revealed that the expression of HAR genes and cryptically spliced genes within putative regions of disease onset differed across FTLD-TDP subtypes. Overall, our findings suggest that FTLD targets brain regions that have undergone recent evolutionary specialization and provide intriguing potential leads regarding the transcriptomic basis for selective vulnerability in distinct FTLD molecular-anatomical subtypes.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: MedRxiv Ano de publicação: 2023 Tipo de documento: Article